AHA Names Top Advances in Cardiovascular Disease Research for 2023

Every year, researchers gain a deeper understanding of the pathways that lead to cardiovascular disease and how to better prevent and treat heart disease and stroke.

In 2023, investigators made important strides toward improving and extending the lives of people affected by these conditions, along with potentially lowering the burden of disease with therapies and strategies that hold promise for prevention.

The groundbreaking STEP-HFpEF study, led by Mikhail Kosiborod, MD, vice president of research at Saint Luke's Health System, has been named one of the top advances by the American Heart Association.

Read the full article: American Heart Association: AHA Names Top Advances in Cardiovascular Disease Research for 2023